| answer text |
<p>All human medicines marketed in the United Kingdom must meet stringent requirements
for quality, safety and efficacy set out in UK medicines legislation and supporting
guidelines. These apply regardless of the source of the medicine.</p><p>The Medicines
and Healthcare products Regulatory Agency (MHRA), the Government body responsible
for the safety and licensing of medicines in the UK, regularly inspect pharmaceutical
manufacturing plants in the UK and in third countries.</p><p>Regardless of the location
of the site of manufacture, the manufacturer must demonstrate to the MHRA that the
product is manufactured according to the registered UK licence (marketing authorisation)
and to at least the minimum standard detailed in the European Union Guide to Good
Manufacturing Practice.</p><p>In addition, each batch of medicine manufactured in
a third country is tested within the UK on import and the manufacturing document reviewed
by the license holders Qualified Person before being certified for release to the
market.</p><p>All these measures will remain in place if the UK leaves the EU.</p>
|
|
